tiprankstipranks

David Domzalski Insider Profile

25 Followers
David Domzalski, President & CEO, Director at Yarrow Bioscience, holds 347.17K shares in Yarrow Bioscience (Ticker: YARW), holds 319.32K shares in Foamix Pharma (Ticker: FOMX).
tipranks
David Domzalski

David Domzalski
Yarrow Bioscience (YARW)
President & CEO, Director

Ranked #5,971 out of 108,921 Corporate Insiders

Profitable Transactions

92%
11 out of 12 Profitable Transactions

Average Return

+25.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$10M
100.00%
A breakdown of David Domzalski's holdings

Insider Roles

Yarrow Bioscience
(YARW)
President & CEO, Director
Roles that David Domzalski holds in companies

Most Profitable Insider Trade

Stock:
Foamix Pharma
(FOMX)
Rating:Informative Sell
Date:Jul 03, 2018 - Jul 03, 2019
Return:+54.20%
The most profitable trade made by David Domzalski

David Domzalski's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Yarrow Bioscience
Jul 24, 2026
President & CEO, Director
Uninformative Sell
70.66K
$9.87M
FOMX
Foamix Pharma
Feb 24, 2020
Uninformative Buy
$954.78K
List of latest transactions for each holding click on a transaction to see David Domzalski's performance on stock

David Domzalski insider profile FAQ

What is the percentage of profitable transactions made by David Domzalski?
The percentage of profitable transactions made by David Domzalski is 92%.
    What is the average return per transaction made by David Domzalski?
    The average return per transaction made by David Domzalski is 25.20%.
      What stocks does David Domzalski hold?
      David Domzalski holds: YARW, FOMX stocks.
        What was David Domzalski’s latest transaction?
        David Domzalski latest transaction was an Uninformative Sell of $70.66K.
          What was David Domzalski's most profitable transaction?
          David Domzalski’s most profitable transaction was an Informative Sell of FOMX stock on July 3, 2018. The return on the trade was 54.20%.
            What is David Domzalski's role in Yarrow Bioscience?
            David Domzalski's role in Yarrow Bioscience is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.